Relay Therapeutics, Inc.
RLAYNasdaqCIK 1812364HealthcareFiscal year ends Dec 31
Reports and events: 100 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338056 |
| 2026-08-0616:11 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338013 |
| 2026-06-0916:35 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-263873 |
| 2026-05-2117:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-234862 |
| 2026-05-1908:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229770 |
| 2026-05-0516:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-206454 |
| 2026-05-0516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206398 |
| 2026-04-2816:05 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001193125-26-186929 |
| 2026-04-2709:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-179404 |
| 2026-03-1608:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-107312 |
| 2026-03-1116:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-102178 |
| 2026-02-2616:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076739 |
| 2026-02-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076617 |
| 2026-02-0307:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-034422 |
| 2025-11-0616:18 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269601 |
| 2025-11-0616:12 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-269536 |
| 2025-08-0716:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105054 |
| 2025-08-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105022 |
| 2025-06-1116:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-139146 |
| 2025-06-0617:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-137162 |
| 2025-06-0416:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-25-134908 |
| 2025-05-0516:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063553 |
| 2025-05-0516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063539 |
| 2025-04-2316:05 ET | DEF 14A | Proxy statementPeriod 2025-06-06 | 0000950170-25-057333 |
| 2025-02-2616:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027756 |
| 2025-02-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027733 |
| 2025-01-1308:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004586 |
| 2024-12-1107:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135207 |
| 2024-11-0616:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122332 |
| 2024-11-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122297 |
| 2024-09-1116:49 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-217296 |
| 2024-09-0908:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-104557 |
| 2024-08-0616:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091837 |
| 2024-08-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091802 |
| 2024-07-1616:15 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-083928 |
| 2024-06-0608:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-069674 |
| 2024-06-0316:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-067952 |
| 2024-05-0216:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052135 |
| 2024-05-0216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-052110 |
| 2024-04-2316:05 ET | DEF 14A | Proxy statementPeriod 2024-06-03 | 0000950170-24-046883 |
| 2024-02-2216:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-018797 |
| 2024-02-2216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-018763 |
| 2024-01-0807:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-002682 |
| 2023-11-0216:17 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058237 |
| 2023-11-0216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-058199 |
| 2023-10-1216:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-053109 |
| 2023-08-0816:25 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039874 |
| 2023-08-0816:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-039822 |
| 2023-05-3116:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-025321 |
| 2023-05-2517:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-024290 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.